🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Asian stocks rise with inflation in focus; China dips on US jitters

Published 2024-09-09, 10:28 p/m
© Reuters.
AXJO
-
JP225
-
HK50
-
NSEI
-
KS11
-
SSEC
-
TOPX
-
CSI300
-

Investing.com-- Most Asian stocks rose on Tuesday tracking an overnight rebound in Wall Street as investors looked to upcoming inflation data for more cues on interest rate cuts. 

Chinese markets lagged their regional peers after U.S. policymakers passed a bill aimed at rolling out fresh restrictions on several Chinese biotechnology companies. Chinese stocks were also hit by a slew of middling economic cues over the past week. 

Other Asian markets were encouraged by overnight gains on Wall Street, as U.S. stocks recovered some measure of bruising losses clocked last week. Focus this week is squarely on key consumer price index inflation data that is likely to factor into the outlook for interest rates. 

U.S. stock index futures fell slightly in Asian trade, suggesting that a Monday rebound may now be stalling.

Chinese stocks sink on more potential US headwinds 

China’s Shanghai Shenzhen CSI 300 and Shanghai Composite indexes fell 0.3% each to a seven-month low, while Hong Kong’s Hang Seng index fell 0.3% to a three-week low. 

WuXi AppTec Co Ltd H (HK:2359) slid 9%, while Hansoh Pharmaceutical Group Co Ltd (HK:3692) fell 6% after the U.S. House of Representatives passed a bill aimed at restricting business, especially government contracts, with Chinese biotech firms. 

The bill still needs to clear the Senate, and is part of the Biosecure Act- which is aimed at limiting access to Americans’ medical and genetic data, which could potentially present a national security threat. 

But the bill presents a major headwind for Chinese biotech firms, several of which have heavy exposure to the U.S. WuXi AppTec is also building a facility in Massachusetts. 

Losses in biotech spilled over into broader Chinese stocks, given that the bill also heralds a worsening in Sino-U.S. relations. 

Chinese markets- especially those in the Mainland- were also battered by a string of middling economic readings for August over the past week. Focus on Tuesday is on trade data for August.

Asian stocks rise with CPI, rate cuts in focus 

Broader Asian markets advanced tracking their Wall Street peers, with focus squarely on CPI inflation data due on Wednesday. The reading comes just a week before a Federal Reserve meeting where the central bank is widely expected to cut interest rates by 25 basis points. 

Japan’s Nikkei 225 and TOPIXindexes rose 0.2% and 0.8%, respectively, after sinking to a near one-month low last week. 

Australia’s ASX 200 added 0.6%, even as data showed consumer sentiment worsened in early-September. 

South Korea’s KOSPI was flat, while futures for India’s Nifty 50 index pointed to a mildly weaker open.

Regional markets clocked steep losses last week as renewed concerns over a global economic slowdown battered risk-driven markets. Japanese stocks were among the worst-hit by this trend, while Indian and Australian markets were mostly resilient. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.